Company intelligence / Profile preview

Peachtree BioResearch Solutions

Marietta, Georgia, United Statespeachtreebrs.com ↗

Ownership: Private
Employees: ~74
Development stage: Other

Overview

Peachtree BioResearch Solutions was a full-service U.S.-based CRO specializing in providing flexible and scalable clinical development services to small and mid-size biotechnology, pharmaceutical, and medical device companies. In May 2025 it merged with Julius Clinical to form an integrated global CRO with expanded capabilities—particularly within CNS and cardio-metabolic research—offering end-to-end support for Phase I–III trials across North America and Europe.

Therapeutic areas: Rare DiseasesCardiovascularNephrologyNeurology
Modalities: Small moleculeBiologicMedical device
Industry: Contract Research Organization

Partnerships

Julius Clinical (merger partner)Ampersand Capital Partners (post-merger)

Beyond the preview

Go deeper on Peachtree BioResearch Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peachtree BioResearch Solutions.

Explore the full profile